Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/ehjci/jead162 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Towards a new role for multimodality imaging in the diagnosis of cancer-associated marantic endocarditis.
Arch Cardiovasc Dis
December 2023
Aix-Marseille University, Cardiology Department, service de cardiologie AP-HM, La Timone Hospital, boulevard Jean-Moulin, 13005 Marseille, France.
Cancer-associated marantic endocarditis: a rare but relevant complication.
Eur Heart J Cardiovasc Imaging
November 2023
Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Location AMC, Meibergdreef 9, Amsterdam 1105 AZ, The Netherlands.
Lung Cancer as a Leading Cause among Paraneoplastic Non-Bacterial Thrombotic Endocarditis: A Meta-Analysis of Individual Patients' Data.
Cancers (Basel)
March 2023
Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY 10021, USA.
Hypercoagulability is strongly associated with cancer and may result in non-bacterial thrombotic endocarditis (NBTE). The aim of our meta-analysis was to explore the demographics and characteristics of this condition in cancer. Databases were systematically searched.
View Article and Find Full Text PDFCancer-associated non-bacterial thrombotic endocarditis.
Thromb Res
May 2022
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel. Electronic address:
Article Synopsis
- This paper explores the pathogenesis, clinical signs, diagnosis, and management of cancer-associated non-bacterial thrombotic endocarditis (NBTE), an often overlooked condition marked by sterile vegetations on heart valves.
- Cancer is the primary cause of NBTE, particularly linked to mucin-releasing adenocarcinomas from various organs, and can lead to significant risks like embolic strokes.
- Effective diagnosis involves transesophageal echocardiography and monitoring of D-dimer levels, while treatment often includes long-term anticoagulation with low molecular weight heparin and urgent cancer management if undiagnosed.
Systemic thromboembolism from a misdiagnosed non-bacterial thrombotic endocarditis in a patient with lung cancer: A case report.
Oncol Lett
November 2020
Medical Oncology Unit, University Hospital of Parma, I-43126 Parma, Italy.
Thromboembolic events are frequent in patients with cancer, commonly involving the venous and pulmonary circulation. The arterial system is rarely implicated in embolism and, when involved, a cardiogenic origin should always be excluded. In the present study, a case of a patient who developed multiple embolic events concomitantly with the diagnosis of locally-advanced non-small cell lung cancer with high expression levels of programmed death-ligand 1 (PD-L1) in >50% of tumor cells is reported.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!